Neuro-Oncology Rational combination platform trial design for children and young adults with diffuse midline glioma


Diffuse midline glioma (DMG) is a devastating pediatric brain tumor unresponsive to hundreds of clinical trials.


Previous
Previous

Neuro-Oncology Rational combination platform trial design

Next
Next

Journal of Clinical Oncology PNOC001: Phase II Study of Everolimus For Recurrent or Progressive Low-Grade Gliomas in Children